ROCHE HLDG LTD (RHHBY)

Overview Price 45.00 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $45.00 Daily Range $0.00 - $0.00 52-Week Range $34.36 - $45.34 Volume 0 Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. The Company distributes its products throughout Europe, the United States, Asia and Latin America. Other Resources for RHHBY Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Speedy Review for Roche Drug February 9, 2012 Zacks Blog: Zacks Bull and Bear of the Day Highlights: Amgen, Montpelier Re Holdings, Cisco Systems, Illumina and Roche Holdings February 9, 2012 Zacks Blog: Life Technologies Beats, Profit Up February 8, 2012 Zacks Blog: Illumina Beats, Spurns Roche Offer February 8, 2012 Zacks Blog: Genomic Misses, Grows Annually February 7, 2012 Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. The Company distributes its products throughout Europe, the United States, Asia and Latin America.   Brokerage Analyst Recommendations 5 Brokerage Firms Covering RHHBY   Strong Buy 4 Buy 0 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.4   RHHBY Ratings: BUY  SELL  HOLD RHHBY Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 0 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	02/09/12	Speedy Review for Roche Drug - Analyst Blog	0
Zacks_Analysts	0.00	02/08/12	Life Technologies Beats, Profit Up - Analyst Blog	0
Zacks_Analysts	0.00	02/08/12	Illumina Beats, Spurns Roche Offer - Analyst Blog	0
Zacks_Analysts	0.00	02/07/12	Genomic Misses, Grows Annually - Analyst Blog	0
Zacks_Analysts	0.00	02/06/12	Earnings Preview: Life Technologies - Analyst Blog	0
Zacks_Analysts	0.00	02/02/12	Merck Beats on EPS, Guides In-Line - Analyst Blog	0
Zacks_Analysts	0.00	02/02/12	Roche Beats; Optimistic about 2012 - Analyst Blog	0
Zacks_Analysts	0.00	02/01/12	Roche Brings Another Drug to Market - Analyst Blog	0
Zacks_Analysts	0.00	01/31/12	EPS Beat for Biogen; Outlook Weak - Analyst Blog	0
Zacks_Analysts	0.00	01/25/12	Roche Aims for Illumina - Analyst Blog	0

Pages: [ 1 ]  2   3   4   5   ...  29  >>

Commentary

There are no open picks with this stock at the moment.

Picks

There are no open picks with this stock at the moment.